ASCO Annual Report Names Significant Clinical Research Advances Of Past Year
Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial
Tykerb Plus Herceptin Better Than Monotherapy, Study Says
Bisphosphonates May Reduce Recurrent Breast Cancer
Study Finds High-Risk Women Reluctant To Take Tamoxifen
Cervical Cancer Screening Can Be Done Later, Less Often
No Benefit For Cetuximab In Early-Stage Colon Cancer
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest
- In the Headlines: MD Anderson’s Pisters on doing “something gigantic for pediatric cancer”
- The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo
- As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures - In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater
